Michael Ghadimi

7.4k total citations · 2 hit papers
179 papers, 2.7k citations indexed

About

Michael Ghadimi is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Ghadimi has authored 179 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Oncology, 70 papers in Surgery and 54 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Ghadimi's work include Colorectal Cancer Surgical Treatments (56 papers), Pancreatic and Hepatic Oncology Research (34 papers) and Colorectal and Anal Carcinomas (32 papers). Michael Ghadimi is often cited by papers focused on Colorectal Cancer Surgical Treatments (56 papers), Pancreatic and Hepatic Oncology Research (34 papers) and Colorectal and Anal Carcinomas (32 papers). Michael Ghadimi collaborates with scholars based in Germany, United States and United Kingdom. Michael Ghadimi's co-authors include Tim Beißbarth, Jochen Gaedcke, Torsten Liersch, Emmanouil Fokas, Heinz Becker, Rolf Sauer, Lena‐Christin Conradi, Claus Rödel, Rainer Fietkau and Hendrik A. Wolff and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Michael Ghadimi

161 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor Regression Grading After Preoperative Chemoradiotherapy for Locally Advanced Rectal Carcinoma Revisited: Updated Results of the CAO/ARO/AIO-94 Trial

2014 324 citations Emmanouil Fokas, Torsten Liersch et al. Journal of Clinical Oncology profile →
Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial).

2024 37 citations Jens Hoeppner, Thomas Brunner et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Michael Ghadimi

Since Specialization

Citations

This map shows the geographic impact of Michael Ghadimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ghadimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ghadimi more than expected).

Fields of papers citing papers by Michael Ghadimi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Ghadimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ghadimi. The network helps show where Michael Ghadimi may publish in the future.

Co-authorship network of co-authors of Michael Ghadimi

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Ghadimi. A scholar is included among the top collaborators of Michael Ghadimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Ghadimi. Michael Ghadimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TP53 missense–specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer 2025 ·Science Advances ·(unknown), (unknown), (unknown), (unknown), Stefan Küffer, Lukas Klein, Christof Lenz, Ulrich Sax, Michael Ghadimi, Ramona Schulz‐Heddergott, Elisabeth Heßmann, Volker Ellenrieder, Nelson Dusetti, Shiv K. Singh	0
2	Ideal Outcome after Left Pancreatectomy in North America, Germany, the Netherlands, and Sweden 2025 ·Annals of Surgery ·T. Hendriks, (unknown), Bodil Andersson, Carl S. Williamson, Joal D. Beane, Catherine Davis, Michael Ghadimi, Jens Werner, Waldemar Uhl, Ulrich F. Wellner, Tobias Keck, Bert A. Bonsing, Bas Groot Koerkamp, Hjalmar C. van Santvoort, Bergþór Björnsson, Marc G. Besselink, Henry A. Pitt, Bobby Tingstedt, (unknown)	0
3	Safety and performance of a synthetic sealant patch aimed to prevent postoperative pancreatic fistula after distal pancreatectomy (SHIELDS) – Prospective international multicenter phase II study 2024 ·HPB ·(unknown), Asmus Heumann, Claudio Bassi, Luca Landoni, (unknown), Michael Ghadimi, (unknown), Frederik Berrevoet, (unknown), Marc G. Besselink, Eduard A. van Bodegraven, Mustapha Adham, Johann Pratschke, Wenzel Schöning, Jakob R. Izbicki, Maximilian Bockhorn	1
4	Management von Verletzungen parenchymatöser Abdominalorgane 2024 ·Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie ·(unknown), (unknown), (unknown), (unknown), Giovanni Torsello, Annemarie Uhlig, Michael Ghadimi, Florian Bösch	0
5	Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial). breakdown → 2024 ·Journal of Clinical Oncology ·Jens Hoeppner, Thomas Brunner, Florian Lordick, Claudia Schmoor, Birte Kulemann, Ulf P. Neumann, Gunnar Folprecht, Tobias Keck, Frank Benedix, (unknown), (unknown), Christiane J. Bruns, Johan Friso Lock, Benedikt Reichert, Michael Ghadimi, Kai Wille, Ines Gockel, Jakob R. Izbicki, Stefan Utzolino, Peter Grimminger	37
6	LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism 2024 ·Carcinogenesis ·Yuuki Ohara, Amanda J. Craig, Huaitian Liu, (unknown), (unknown), Tiffany H. Dorsey, Helen Cawley, Azadeh Azizian, Jochen Gaedcke, Michael Ghadimi, Nader Hanna, Stefan Ambs, S. Perwez Hussain	4
7	ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer 2024 ·International Journal of Cancer ·Yuuki Ohara, Huaitian Liu, Amanda J. Craig, Shouhui Yang, (unknown), Tiffany H. Dorsey, Helen Cawley, Azadeh Azizian, Jochen Gaedcke, Michael Ghadimi, Nader Hanna, Stefan Ambs, S. Perwez Hussain	4
8	MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK–ERK and AP-1 pathways 2024 ·Carcinogenesis ·(unknown), Wei Tang, Azadeh Azizian, Jochen Gaedcke, Yuuki Ohara, Helen Cawley, Nader Hanna, Michael Ghadimi, (unknown), Subrata Sen, Chad J. Creighton, Jianjun Gao, Nagireddy Putluri, Stefan Ambs, S. Perwez Hussain	7
9	ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer 2024 ·Carcinogenesis ·(unknown), Yuuki Ohara, Amanda J. Craig, (unknown), (unknown), Tiffany H. Dorsey, (unknown), Gatikrushna Panigrahi, Helen Cawley, Azadeh Azizian, Jochen Gaedcke, Michael Ghadimi, Nader Hanna, S. Perwez Hussain	5
10	Visualization of deglutition and gastroesophageal reflux using real-time MRI: a standardized approach to image acquisition and assessment 2023 ·Scientific Reports ·(unknown), Johannes Uhlig, (unknown), (unknown), Edris Wedi, Ahmad Amanzada, Volker Ellenrieder, (unknown), Michael Ghadimi, Jens Frahm, Martin Uecker, Ali Seif Amir Hosseini	1
11	Whole 16S rRNA sequencing of the oral microbiome predicts postoperative pancreatic fistula: prospective observational cohort study 2023 ·British journal of surgery ·Christoph Ammer‐Herrmenau, (unknown), (unknown), (unknown), (unknown), Jacob Hamm, S Buchholz, Azadeh Azizian, Michael Ghadimi, Volker Ellenrieder, Albrecht Neeße	0
12	Randomized phase III trial of induction chemotherapy followed by chemoradiotherapy or chemotherapy alone for non-resectable locally advanced pancreatic cancer: First results of the CONKO-007 trial 2023 ·Zeitschrift für Gastroenterologie ·Robert Grützmann, Michael Ghadimi, Waldemar Uhl, Uwe A. Wittel, Wolf O. Bechstein, A. Reinacher-Schick, Andrea Tannapfel, Helmut Oettle, Rainer Fietkau	0
13	Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial 2022 ·Cancers ·Markus Diefenhardt, Daniel Martin, Ethan B. Ludmir, Maximilian Fleischmann, Ralf‐Dieter Hofheinz, Michael Ghadimi, (unknown), Bülent Polat, Tim Friede, Bruce D. Minsky, Claus Rödel, Emmanouil Fokas	4
14	Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial 2020 ·European Journal of Cancer ·(unknown), Emmanouil Fokas, Michael Flentje, Rolf Sauer, Torsten Liersch, Ullrich Graeven, Rainer Fietkau, Werner Hohenberger, Dirk Arnold, Ralf‐Dieter Hofheinz, Michael Ghadimi, Philipp Ströbel, Ludger Staib, Gerhard G. Grabenbauer, Gunnar Folprecht, Simon Kirste, Wolfgang Uter, Christine M. Gall, Claus Rödel, Bülent Polat	13
15	Favorable 90-Day Mortality in Obese Caucasian Patients with Septic Shock According to the Sepsis-3 Definition 2019 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), Benedikt Büttner, José Hinz, Aron‐Frederik Popov, Michael Ghadimi, Tim Beißbarth, Dirk Raddatz, Konrad Meissner, Michael Quintel, Ingo Bergmann, Ashham Mansur	14
16	Lack of an Association between the Functional Polymorphism TREM-1 rs2234237 and the Clinical Course of Sepsis among Critically Ill Caucasian Patients—A Monocentric Prospective Genetic Association Study 2019 ·Journal of Clinical Medicine ·(unknown), (unknown), Benedikt Büttner, José Hinz, Aron‐Frederik Popov, Michael Ghadimi, Koloman Krištof, Tim Beißbarth, (unknown), Mladen V. Tzvetkov, Bastian Schmack, Michael Quintel, Ingo Bergmann, Ashham Mansur	6
17	CTLA-4 Genetic Variants Predict Survival in Patients with Sepsis 2019 ·Journal of Clinical Medicine ·(unknown), Benedikt Büttner, José Hinz, Ayelet Alpert, Aron‐Frederik Popov, Michael Ghadimi, Tim Beißbarth, Mladen V. Tzvetkov, Ole Jensen, (unknown), Michael Quintel, Shai S. Shen-Orr, Ingo Bergmann, Ashham Mansur	17
18	Long-term prognostic impact of surgical complications in the German Rectal Cancer Trial CAO/ARO/AIO-94 2018 ·British journal of surgery ·Thilo Sprenger, Tim Beißbarth, Rolf Sauer, Jörg Tschmelitsch, Rainer Fietkau, Torsten Liersch, Werner Hohenberger, Ludger Staib, Jochen Gaedcke, (unknown), Claus Rödel, Michael Ghadimi	43
19	The expression of hematopoietic progenitor cell antigen CD34 is regulated by DNA methylation in a site‐dependent manner in gastrointestinal stromal tumours 2017 ·International Journal of Cancer ·Irina V. Bure, Alexander Braun, (unknown), Helene Geddert, Inga‐Marie Schaefer, Silke Cameron, Michael Ghadimi, Philipp Ströbel, Martin Werner, Arndt Hartmann, Stefan Wiemann, Abbas Agaimy, Florian Haller, Evgeny A. Moskalev	6
20	Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) Analysis 2016 ·International Journal of Molecular Sciences ·Roland S. Croner, (unknown), Metodi V. Metodiev, Peter Jo, Michael Ghadimi, Vera Schellerer, (unknown), (unknown), Tilman T. Rau, Michael Stürzl, Elisabeth Naschberger, Klaus E. Matzel, Werner Hohenberger, Friedrich Lottspeich, Josef Kellermann	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact